Intracranial Pressure and a Potential Vicious Circle of Atrial Fibrillation in HFpEF
heart failure
INTRACRANIAL PRESSURE AND A POTENTIAL VICIOUS CIRCLE OF ATRIAL FIBRILLATION IN HFPEF
1 other identifier
observational
309
1 country
1
Brief Summary
This study was designed to investigate predictors of atrial fibrillation (AF) in patients with heart failure with preserved ejection fraction (HFpEF), with a particular focus on the potential relationship between venous congestion and intracranial pressure dynamics. Among HFpEF patients, those with AF exhibited significantly higher right atrial pressure (RAP), larger right atrial area, higher CHA₂DS₂-VA scores, and increased optic nerve sheath diameter (ONSD), a noninvasive surrogate marker of intracranial pressure. In multivariable logistic regression analysis, increased ONSD, elevated RAP, larger right atrial area, and higher CHA₂DS₂-VA score remained independently associated with AF, suggesting that both systemic venous congestion and intracranial pressure-related mechanisms may contribute to AF susceptibility in this population. These findings support the hypothesis of a cardio-cerebral interaction in HFpEF, in which elevated right-sided filling pressures may impair cerebrospinal fluid drainage, increase intracranial pressure, and potentially promote AF through autonomic and hemodynamic pathways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 20, 2026
CompletedFirst Submitted
Initial submission to the registry
April 3, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedApril 9, 2026
March 1, 2026
5 months
April 3, 2026
April 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Atrial fibrillation status (AF vs sinus rhythm) in HFpEF patients
The primary analysis evaluates the association of ONSD, RAP, and the right atrial area with AF status.
Baseline
Presence of atrial fibrillation in patients with HFpEF
The rhythm status was measured by electrocardiography and documented. The primary analysis evaluates the association of ONSD, RAP, and right atrial area with AF status.
At baseline (cross-sectional assessment)
Study Arms (3)
Group 1
Individuals without HFpEF or atrial fibrillation were used as the reference group.
group2
HFpEF With Sinus Rhythm
group 3
HFpEF With Atrial Fibrillation
Interventions
Standard transthoracic echocardiography, including EF, E/e', TRV, atrial areas, SPAP, and estimated right atrial pressure.
Eligibility Criteria
A total of 309 subjects aged approximately 60-78 years with available cranial MRI data were enrolled, including a control group (n = 106), HFpEF patients in sinus rhythm (n = 111), and HFpEF patients with atrial fibrillation (n = 92).
You may qualify if:
- Adults aged approximately 60-78 years with available cranial MRI , HFpEF patients in sinus rhythm, HFpEF patients with atrial fibrillation No HFpEF patients(control) -
You may not qualify if:
- Patients with heart failure and reduced ejection fraction (EF \<50%), known intracranial hypertension, optic nerve or other neurological disorders, chronic obstructive pulmonary disease, clinically significant goiter, liver cirrhosis, renal failure, severe valvular heart disease, congenital heart disease, and advanced diabetes mellitus requiring insulin therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Ataturk Strh
Ankara, Ankara, 06310, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
şahbender koç, MD
AnkaraAtatürk STRH
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- cardıologıst md
Study Record Dates
First Submitted
April 3, 2026
First Posted
April 9, 2026
Study Start
October 14, 2025
Primary Completion
March 20, 2026
Study Completion
March 20, 2026
Last Updated
April 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning 6 months after publication and ending 5 years after publication
- Access Criteria
- Qualified researchers with a scientifically sound proposal may access de-identified IPD, the study protocol, SAP, and analytic code upon written request to the corresponding author, subject to ethics approval and data use agreement.
De-identified individual participant data will be available upon reasonable request for academic research purposes, subject to ethics committee approval and data protection policies.